RGD Reference Report - High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats.

Authors: Thabut, D  Tazi, KA  Bonnefont-Rousselot, D  Aller, M  Farges, O  Guimont, MC  Tellier, Z  Guichard, C  Ogier-Denis, E  Poynard, T  Moreau, R  Lebrec, D 
Citation: Thabut D, etal., Hepatology. 2007 Dec;46(6):1893-906.
RGD ID: 2292126
Pubmed: PMID:17918268   (View Abstract at PubMed)
DOI: DOI:10.1002/hep.21875   (Journal Full-text)

In patients with cirrhosis, endotoxic shock is a major complication of portal hypertension, which is related partly to intrahepatic endothelial nitric oxide synthase (eNOS) down-regulation. High-density lipoproteins (HDLs), whose plasma levels are reduced in cirrhosis, have an anti-inflammatory effect by neutralizing circulating lipopolysaccharide (LPS), and they increase eNOS activity in endothelial cells. Therefore, the aim of this study was to assess the effects of reconstituted high-density lipoprotein (rHDL) administration on the LPS-induced proinflammatory response, intrahepatic eNOS regulation, and portal hypertension in cirrhotic rats. Cirrhotic and control rats were pretreated with rHDL or saline and challenged with LPS or saline. The neutralization of LPS in HDL was assessed by the measurement of HDL-bound fluorescent LPS levels. Plasma tumor necrosis factor alpha (TNFalpha) and lipopolysaccharide binding protein (LBP) levels were measured. The expression of hepatic TNFalpha, LBP, inducible nitric oxide synthase (iNOS), and caveolin-1 (a major eNOS inhibitor) and the activity of protein kinase B (Akt; a major eNOS activator) and eNOS were determined. The portal pressure was measured. The plasma HDL levels were significantly lower in cirrhotic rats than in control rats. In cirrhotic rats, the plasma levels of HDL-bound fluorescent LPS were 50% lower than those in controls, and they were restored after rHDL administration. The plasma TNFalpha levels were significantly higher in LPS-challenged cirrhotic rats than in controls and significantly decreased after rHDL administration. rHDL administration decreased hepatic TNFalpha, LBP, iNOS, and caveolin-1 expression, restored hepatic eNOS and Akt activity, and significantly lowered the portal pressure and intrahepatic vascular resistance. Conclusion: In cirrhotic rats, rHDL administration decreases the hepatic proinflammatory signals induced by LPS, restores the hepatic eNOS activity, and lowers the portal pressure. This suggests that the decrease in circulating HDL in cirrhosis plays a role in the excessive proinflammatory response and intrahepatic eNOS down-regulation.

RGD Manual Disease Annotations    Click to see Annotation Detail View
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
Experimental Liver Cirrhosis  ISONos3 (Rattus norvegicus)2292126; 2292126protein:decreased expression:liverRGD 
Experimental Liver Cirrhosis  IEP 2292126protein:decreased expression:liverRGD 
liver cirrhosis  ISOLbp (Rattus norvegicus)2292126; 2292126protein:increased expression:liverRGD 
liver cirrhosis  IEP 2292126protein:increased expression:liverRGD 

Gene Ontology Annotations    Click to see Annotation Detail View

Biological Process
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
cellular response to high density lipoprotein particle stimulus  IEP 2292126 RGD 

Objects Annotated

Genes (Rattus norvegicus)
Lbp  (lipopolysaccharide binding protein)
Nos3  (nitric oxide synthase 3)

Genes (Mus musculus)
Lbp  (lipopolysaccharide binding protein)
Nos3  (nitric oxide synthase 3, endothelial cell)

Genes (Homo sapiens)
LBP  (lipopolysaccharide binding protein)
NOS3  (nitric oxide synthase 3)


Additional Information